Author

Susanne Kossatz

TUM KlinikumORCID 0000-0002-1908-1782Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Organism:human· 3 Assay:imaging· 2 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Ali AzhdariniaiD· 1 shared Anna Erika WeberiD· 1 shared Christian Ritschel· 1 shared Claus FeldmanniD· 1 shared Clemens DecristoforoiD· 1 shared Fernando A Patiño Álvarez· 1 shared Florian C. BassermanniD· 1 shared Giacomo GariglioiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ali AzhdariniaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

High Drug-Loading Rucaparib-FdUMP Nanocarriers for Colorectal Cancer Combination Therapy

Anna Erika Weber, Christian Ritschel, Claus Feldmann, Susanne Kossatz

This paper develops high drug-loading nanocarriers for co-delivering rucaparib and FdUMP in colorectal cancer, showing synergistic cytotoxicity and DNA damage.

bioRxiv · May 28, 2026 · PreprintCancer Biology

Synthesis and Preclinical Development of a Novel 68Ga/89Zr-Labelled α{nu}β6-Integrin Targeting Trimer

Giacomo Gariglio, Fernando A Patiño Álvarez, Maximilian Alexander Zierke, Stefan Stangl, Tim Rheinfrank, Nadine Holzleitner, Susanne Kossatz, Clemens Decristoforo

This paper develops a novel radiolabeled tracer for v{beta}6 integrin targeting, evaluates its affinity and uptake, and compares its performance to an existing tracer.

EJNMMI Radiopharmacy and Chemistry · Feb 5, 2026Peer-reviewedCancer Biology

Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells

Nghia Trong Nguyen, Yu Min, Jennifer Rivière, Mark van der Garde, Sukhen C. Ghosh, Laura M. Bartos, Matthias Brendel, Florian C. Bassermann, Ali Azhdarinia, Wolfgang Weber, Katharina S. S. Götze, Susanne Kossatz

This paper shows that hematopoietic stem and progenitor cells express somatostatin receptors, leading to unexpected toxicity from radiopharmaceuticals used in neuroendocrine tumors.

Theranostics · May 25, 2025Peer-reviewedCancer Biology